Ampicillin D9 glutamate-cysteine ligase catalytic subunit (Gclc)

glutamate-cysteine ligase catalytic subunit (Gclc) and glutamate-cysteine ligase regulatory subunit (Gclm)

PubMed Central PMCID: PMC4308844

Haemophilus influenzae

289499-45-2 (Canertinib HCl)

indicating a functional role for HGF/c-Met axis in the sunitinib-resistant tumors

Ampicillin D9 glutamate-cysteine ligase catalytic subunit (Gclc)Ampicillin is an antibiotic used to prevent and treat a number of bacterial infections. This includes respiratory tract infections, urinary tract infections, meningitis, salmonella infections, and endocarditis. It may also be used to prevent group B streptococcal infection in newborns. It is used by mouth, by injection into a muscle, or intravenously. It is not useful for the treatment of viral infections. Ampicillin was developed in 1961. It is on